Salta al contenuto principale

Malattia di Schamberg

Benign dermatoses with pupura

Professionisti Medici

Gli articoli di riferimento professionale sono progettati per essere utilizzati dai professionisti della salute. Sono scritti da medici del Regno Unito e basati su prove di ricerca, linee guida del Regno Unito ed europee. Potresti trovare uno dei nostri articoli sulla salute più utile.

What is Schamberg's disease?

Synonyms: progressive pigmented purpuric dermatitis, Gougerot-Blum capillaritis, itching purpura, pigmented purpuric eruption1

Schamberg's disease is the most common type of the pigmented purpuric dermatoses (PPDs). It is chronic, benign, cutaneous eruptions characterised by petechiae, purpura and increased skin pigmentation (brown, red, or yellow patchy). The PPDs are grouped into:

  • Progressive pigmentary purpura or Schamberg's disease.

  • Pigmented purpuric lichenoid dermatitis of Gougerot and Blum - red/brown papules and plaques in men - which responds to psoralen combined with ultraviolet A (PUVA) treatment.

  • Purpura annularis telangiectodes - rare, with a preponderance in young females and manifesting as annular erythematous plaques and patches.

  • Eczematoid-like purpura of Doucas and Kapetanakis - occurring in men, with bilateral intensely itchy lesions on legs.

  • Lichen aureus - a localised persistent form of pigmented purpuric dermatitis.

  • Itching purpura of Lowenthal (disseminated pruriginous angiodermatitis) - rare (like Schamberg's disease) but accompanied by itching.

There is clinical and histological overlap between these and they may actually represent variable presentations of the same disease process.

Who is affected by Schamberg disease? (Epidemiology)

Schamberg's disease is rare and there are few epidemiological studies in the literature.

Schamberg disease may affect all ages but commonly occurs in middle-aged to older men and less frequently in children, although cases have been reported in children aged under two. 2

There has been a case report of four family members with Schamberg's disease, suggesting a possible genetic link.3

Schamberg's disease causes (aetiology) 4

The underlying cause is not known. However, the following have been postulated:

  • Recent viral infection.

  • Alcohol intake.

  • Hypersensitivity to an unknown causal agent.

  • Aberrant cell-mediated immunity (perivascular infiltrate has specific types of CD cells only).

  • Associated with certain medications - thiamine, aspirin, chlordiazepoxide and paracetamol. It has also been reported with bezafibrate and amlodipine.5

  • There is an association with hepatitis B, in which case treatment of the hepatitis may improve the skin.

Schamberg's disease symptoms4

There are no symptoms of Schamberg's disease apart from itching and patients noting their skin looks blotchy. For some this is enough to cause psychological distress. However, some patients have reported pains in their limbs - which may be coincidental.

Lesions are most commonly on the lower limbs bilaterally but can occur anywhere or be unilateral. A case involving the genitals has been reported.

The lesions consist of:

  • Asymmetrical brown/orange patches.

  • Non-blanchable purpura.

  • Petechiae called 'cayenne pepper spots' (develop at the edge of old lesions).

Patterns can vary - for example, annular, linear. There may also be associated lichenification, scaling and pruritic marks.

Diagnosi differenziale16

Other causes of pigmented purpura include:

Indagini

  • Blood tests - including platelets and clotting - are usually normal.

  • Autoantibody screen and hepatitis serology should be performed.

  • Skin biopsy - histology reveals a capillaritis of dermal vessels. Other changes that may be seen include perivascular inflammatory infiltrate, endothelial hypertrophy with extravasation of blood cells and haemosiderin-laden macrophages.9

  • Examination of the skin, using a dermatoscope, may be helpful although there are limited reports in the literature.110

Malattie associate11 12

Schamberg's disease treatment and management1 4 11

Any suspected precipitants should be withdrawn.

  • Pruritis - treat with mild topical corticosteroid or antihistamines.

  • Good results have been obtained with narrow-band ultraviolet light.

  • Aminaphtone, a drug normally used in other venous conditions such as chronic venous congestion of the lower limbs can be used.13

  • Superimposed infection - will need antibiotics.

  • Systemic steroids provide some benefits but these are outweighed by the risks of systemic side-effects.

  • Advanced fluorescent technology using pulses of light has produced some promising cosmetic results.1415

Other tried treatments include vitamin C supplements, laser therapy and wearing support hosiery to prevent venous stasis. There is no evidence from randomised blinded trials of definite benefit of the former two, although case studies exist suggesting benefits from both. Immunosuppressants have also been used. PUVA treatment has been used successfully.2

Prognosi

Schamberg's disease usually runs a chronic course with frequent exacerbations and remissions. The rash may be present for many years with slow extension. Pigmented purpura may occasionally disappear spontaneously.

Aggiornamenti esclusivi per i professionisti sanitari

Rimani informato con gli ultimi aggiornamenti clinici, approfondimenti professionali e linee guida basate su evidenze. La newsletter Patient Pro seleziona contenuti essenziali per i professionisti sanitari—consegnati direttamente nella tua casella di posta.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

Ulteriori letture e riferimenti

  1. Zaldivar Fujigaki JL, Anjum F; Malattia di Schamberg. StatPearls, gen 2026
  2. Spigariolo CB, Giacalone S, Nazzaro G; Pigmented Purpuric Dermatoses: A Complete Narrative Review. J Clin Med. 2021 May 25;10(11). pii: jcm10112283. doi: 10.3390/jcm10112283.
  3. Sethuraman G, Sugandhan S, Bansal A, et al; Familial pigmented purpuric dermatoses. J Dermatol. 2006 Sep;33(9):639-41.
  4. Capillaritis; DermNet NZ
  5. Schetz D, Kocic I; A new adverse drug reaction - Schamberg's disease caused by amlodipine administration - a case report. Br J Clin Pharmacol. 2015 Aug 10. doi: 10.1111/bcp.12742.
  6. Ho C, Yan P, Mistry N, et al; Dermacase: Can you identify this condition? 4. Progressive pigmented purpuric Can Fam Physician. 2010 Oct;56(10):1023, 1024-5.
  7. Ugajin T, Satoh T, Yokozeki H, et al; Mycosis fungoides presenting as pigmented purpuric eruption. Eur J Dermatol. 2005 Nov-Dec;15(6):489-91.
  8. Nikam BP, Singh NJ, Shetty DD; Primary benign hypergammaglobulinemic purpura of Waldenstrom masquerading as disseminated Schamberg's purpura. Indian J Dermatol Venereol Leprol. 2011 Mar-Apr;77(2):205-8.
  9. Billings S et al; Inflammatory Dermatopathology: A Pathologist's Survival Guide, 2010.
  10. Khopkar U; Dermoscopy and Trichoscopy in Diseases of the Brown Skin, 2013.
  11. Kim DH, Seo SH, Ahn HH, et al; Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis. Ann Dermatol. 2015 Aug;27(4):404-10. doi: 10.5021/ad.2015.27.4.404. Epub 2015 Jul 29.
  12. Sardana K, Sarkar R, Sehgal VN; Pigmented purpuric dermatoses: an overview; Int J Dermatol. 2004 Jul;43(7):482-8.
  13. de Godoy JM, Batigalia F; Aminaphtone in the control of Schamberg's disease. Thromb J. 2009 Jun 11;7:8.
  14. Manolakos DA, Weiss J, Glick B, et al; Treatment of Schamberg's disease with advanced fluorescence technology. J Drugs Dermatol. 2012 Apr;11(4):528-9.
  15. Demidion DV, Olisova OY, Kostenko AY, et al; Complete clearance of Schamberg disease lesions with intense pulsed light. Photodermatol Photoimmunol Photomed. 2023 Jan;39(1):78-81. doi: 10.1111/phpp.12810. Epub 2022 Jun 14.
  16. Shen A et al; Capillaritis as a potential harbinger of cutaneous T-cell lymphoma, 2004

Informazioni sull'autoreVisualizza il profilo completo

Immagine dell'autore

Dr Toni Hazell, MRCGP

MBBS, BSc, MRCGP, DFSRH, Dip GU med, DRCOG, DCH (London, UK, 2000)

La Dott.ssa Toni Hazell si è laureata presso la St. Mary’s Hospital Medical School e ha completato il suo VTS al Northwick Park Hospital.

Informazioni sul recensoreVisualizza il profilo completo

Immagine dell'autore

Dr Philippa Vincent, MRCGP

Medico di base, Autore medico

MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG

Dr Philippa Vincent è un medico di base del NHS che lavora nel nord di Londra.

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.

verifica idoneità al vaccino antinfluenzale

Chiedi, condividi, connettiti.

Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

verificatore di sintomi

Non ti senti bene?

Valuta i tuoi sintomi online gratuitamente